1Zhang JY, Zhang Z, Jin B, et al. Cutting edge : programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-speeific CD8 * T cells in acute self-limited hepatitis B virus infection[J]. J Immunol, 2008,181 ( 6 ) : 3741-3744.
2Muenst S,Soysal SD,Tzankov A,et al. The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treat- ment target in immunotherapy [ J ]. Expert Opin Ther Targets, 2015,19(2) :201-211.
3Dai S, Jia R, Zhang X, et al. The PD-1/PD-Ls pathway and autoim- mune diseases[ J]. Cell Immunol,2014,290 ( 1 ) :72-79.
4Boussiotis VA, Chatterjee P, Li L. Biochemical signaling of PD-1 on T cells and its functional implications [ J]. Cancer J,2014,20 (4) :265-271.
5E1 Annan J, Goyal S, Zhang Q, et al. Regulation of T-cell cbemo- taxis by programmed death-ligand 1 ( PD-L1 ) in dry eye-associated corneal inflammation [ J ]. Invest Ophthalmol Vis Sci, 2010, 51 (7) :3418-3423.
6Liu Y, Zhao M, Xu X, et al. Adoptive transfer of Treg cells counters adverse effects of Toxoplasma gondii infection on pregnancy [ J ]. J Infect Dis,2014,210(9) : 1435-1443.
7Ghiotto M, Ganthier L, Serriari N, et al. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1 [ J ]. Int Im- munol,2010,22 (8) :651-660.
8Tang X, Li Q, Zhu Y, et al. The advantages of PD1 activating chim- eric receptor (PD1-ACR) engineered lymphocytes for PDL1 ( + ) cancer therapy[ J]. Am J Transl Res,2015,7 ( 3 ) :460-473.
9Butte M J, Pena-Cruz V, Kim M J, et al. Interaction of human PD-L1 and B7-1 [J]. Mol Immunol,2008,45(13) :3567-3572.
10Won TJ, Jung Y J, Kwon SJ, et al. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes [ J ]. Arch Pharm Res ,2010,33 ( 11 ) : 1825-1833.
